British aseptic finish experts Flexicon Liquid Filling have launched Cellefill, a turnkey, vial fill system with an integrated barrier solution.
Cellefill integrates the features of Flexicon's FPC60 aseptic vial filling machine with barrier technologies from Franz Ziel. Cellefill's process design includes use of asepticsu single-use-systems (SUS) and pre-sterilised ready to use (RTU) product containers that enter the Grade A filling zone by a No Touch Transfer (NTT) debagging system.
The solution is also GMP compliant and delivers enhanced levels of process flexibility to accelerate production of ATMPs and biological therapies.
Flexicon is a brand of Watson-Marlow Fluid Technology Solutions (WMFTS) and barrier technology specialists Franz Ziel GmbH.
Designed to suit various filling requirements and class cleanrooms, the Cellefill solution is available in three models with different barrier technologies. Each model delivers enhanced levels of process and quality assurance with highly accurate peristaltic pump performance, integrated barrier and environmental monitoring.
We are a committed project partner to biopharmaceutical companies at the cutting-edge of personalised medicine
Steve Adams, Product Manager for Cellefill at WMFTS, said: "Through process flexibility, Cellefill enables the scale out and process repeatability our customers need to assure product quality at all levels of manufacturing. Providing expert guidance and support through a single point of contact, we are a committed project partner to biopharmaceutical companies at the cutting-edge of personalised medicine.
Cellefill builds on the partner's experience in providing technology and extensive support through validation, qualification and operator training to facilitate a smooth transition into GMP compliant and cost-effective manufacturing.
Adams added: "The challenge for the industry is to produce these new therapies quickly, safely and cost efficiently, with a system that can be rapidly changed between batch or different small batch medicines."
Markus Hoersch, division manager sales and marketing from Franz Ziel said: "Cellefill is a fully integrated vial fill/finish and barrier technology solution supporting enhanced levels of product quality and sterility assurance to mitigate risks of contamination. Cellefill adopts pre-designed and configurable modules to reduce project time and fast track therapies to market.
Cellefill minimises batch changeover time with enhanced cleanability, rapid Vapour-phase Hydrogen Peroxide (VHP) cycle times and gloveless operation in the aseptic core, while retaining the possibility of risk-based compliant interventions if needed in rare incidences to prevent batch loss.
The Cellefill solution enables a streamlined project timeline with integrated technical and GMP documentation to increase efficiency of the project validation and qualification stages.
